Omnicell

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Omnicell and other ETFs, options, and stocks.

About OMCL

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. 

CEO
Randall A. Lipps
CEORandall A. Lipps
Employees
3,580
Employees3,580
Headquarters
Fort Worth, Texas
HeadquartersFort Worth, Texas
Founded
1992
Founded1992
Employees
3,580
Employees3,580

OMCL Key Statistics

Market cap
2.01B
Market cap2.01B
Price-Earnings ratio
100.66
Price-Earnings ratio100.66
Dividend yield
Dividend yield
Average volume
498.42K
Average volume498.42K
High today
$45.11
High today$45.11
Low today
$44.00
Low today$44.00
Open price
$44.48
Open price$44.48
Volume
396.02K
Volume396.02K
52 Week high
$55.00
52 Week high$55.00
52 Week low
$26.85
52 Week low$26.85

Stock Snapshot

With a market cap of 2.01B, Omnicell(OMCL) trades at $44.10. The stock has a price-to-earnings ratio of 100.66.

On 2026-05-26, Omnicell(OMCL) stock moved within a range of $44.00 to $45.11. With shares now at $44.10, the stock is trading +0.2% above its intraday low and -2.2% below the session's peak.

Trading volume for Omnicell(OMCL) stock has reached 396.02K, versus its average volume of 498.42K.

The stock's 52-week range extends from a low of $26.85 to a high of $55.00.

The stock's 52-week range extends from a low of $26.85 to a high of $55.00.

OMCL News

Nasdaq 2d
Omnicell Stock Surges 57.3% in a Year: What's Driving It?

Omnicell OMCL has seen impressive growth over the past year, with its shares jumping 57.3%. It has significantly outperformed the industry’s 30.3% fall and the...

Omnicell Stock Surges 57.3% in a Year: What's Driving It?
Simply Wall St 3d
Omnicell Valuation Check After Earnings Beat And Upgraded Analyst Outlook

Recent quarterly results from Omnicell (OMCL) topped expectations for both revenue and profit, prompting analysts to lift their outlook and tighten consensus ar...

Omnicell Valuation Check After Earnings Beat And Upgraded Analyst Outlook
Simply Wall St 5d
Is It Too Late To Consider Omnicell After A 63% One-Year Share Price Surge?

If you are wondering whether Omnicell's current share price still reflects good value or if most of the opportunity is already priced in, the starting point is...

Is It Too Late To Consider Omnicell After A 63% One-Year Share Price Surge?

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More OMCL News

TipRanks 5d
Omnicell announces removal of i.vSTATION syringe labels

The FDA is aware that Omnicell (OMCL) has issued a letter to affected customers recommending certain syringe labels used with the i.v.STATION automated compound...

TipRanks 7d
Omnicell Earnings Call Highlights Profits and Momentum

Omnicell ((OMCL)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful i...

People also own

Based on the portfolios of people who own OMCL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.